secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0001493152-24-025884
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders elect directors, approve equity plan increase and auditor ratification
--------------------------------------------------------------------------------

- All six director nominees (Yorke, Ng, Baluch, Neal, Pannu, Young) elected with over 878K 'For' votes each.
- Amendment to 2019 Omnibus Incentive Plan increasing share pool by 500,000 shares approved (779,164 for, 176,802 against).
- Ratification of BD & Company as independent auditor for 2024 passed with 1,490,908 for, 32,346 against.
- Advisory vote on executive compensation approved with 804,087 for, 164,034 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/0001493152-24-025884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224025884/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer